Explore Cyclo Therapeutics, Inc.'s latest 8-K filing, revealing critical stock and warrant details essential for investors. Get insights on CYTH and CYTHW as of January 10, 2025.
Explore Cyclo Therapeutics, Inc.'s 8-K filing from January 3, 2025, detailing critical corporate events, financial disclosures, and stock information relevant to investors.
Explore Cyclo Therapeutics' 8-K report filed on December 18, 2024, detailing stock and warrants. Learn about their SEC compliance and trading on NASDAQ (CYTH, CYTHW).
Discover Cyclo Therapeutics, Inc.'s latest 8-K report filed on October 20, 2023, detailing stock and warrant info for investors. Key data on equity structure and compliance included.
Discover Cyclo Therapeutics, Inc.'s latest 8-K report highlighting stock updates, warrants, and equity insights as of April 20, 2023. Stay informed on CYTH and CYTHW.
Explore Cyclo Therapeutics, Inc.'s 8-K filing from November 16, 2021, detailing stock info, CIK, and warrants on NASDAQ. Key financial insights included.
Discover Cyclo Therapeutics' latest 8-K report from Dec 27, 2023, detailing corporate actions, common stock, and warrants. Stay informed on crucial developments for investors.
Explore Cyclo Therapeutics, Inc.'s financial report detailing stock classifications, warrants, and regulatory compliance as of August 1, 2023. Essential for investors and analysts.
Discover key details from Cyclo Therapeutics' 8-K report on their recent $1.87M stock sale, underwritten by Maxim Group, LLC, and additional warrant issuance.
Explore Cyclo Therapeutics' 8-K filing from September 21, 2023, detailing stock info, compliance, and potential investor implications.
Discover Cyclo Therapeutics, Inc.'s latest 8-K report filed on June 24, 2022. Get insights on common stock, warrants, and essential company information.
Explore Cyclo Therapeutics, Inc.'s latest 8-K filing from December 26, 2023, detailing common stock and warrants, impacting investors' decisions.